Medicine, Hepatology Division

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Liver Medicine & Life Sciences
Liver Transplantation Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences
Transplants Medicine & Life Sciences
Liver Diseases Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Fibrosis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Steven L Flamm

Steven L Flamm

Person: Academic

19942021
No photo of Daniel R Ganger

Daniel R Ganger

Person: Academic

19802021
No photo of Richard Green

Richard Green

Person: Academic

19912023

Research Output 1980 2019

1 Citation (Scopus)

A comprehensive pipeline for translational top-down proteomics from a single blood draw

Toby, T. K., Fornelli, L., Srzentić, K., DeHart, C. J., Levitsky, J., Friedewald, J. J. & Kelleher, N. L., Jan 1 2019, In : Nature Protocols. 14, 1, p. 119-152 34 p.

Research output: Contribution to journal › Article

Proteomics
Blood
Pipelines
Fractionation
Mass spectrometry
1 Citation (Scopus)

AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis

American Gastroenterological Association Institute Clinical Guidelines Committee, Feb 1 2019, In : Gastroenterology. 156, 3, p. 748-764 17 p.

Research output: Contribution to journal › Article

Ulcerative Colitis
Practice Guidelines
2 Citations (Scopus)

Age and liver transplantation

Durand, F., Levitsky, J., Cauchy, F., Gilgenkrantz, H., Soubrane, O. & Francoz, C., Apr 1 2019, In : Journal of Hepatology. 70, 4, p. 745-758 14 p.

Research output: Contribution to journal › Review article

Liver Transplantation
Tissue Donors
Transplants
End Stage Liver Disease
Brain Death

Grants 2002 2023

Prot#CVAY736B2201: A Two-Part Randomized, Double-Blind, Placebo-Controlled Multicenter Dose Ranging and Confirmatory Study to Assess the Safety and Efficacy of VAY736 in Autoimmune Hepatitis Patients with Incomplete Response to or Intolerance of Standard

Flamm, S. L.

Novartis Pharmaceuticals Corporation

1/14/19 → 12/31/21

Project: Research project

NU 18I03 - Pilot Study of Nivolumab in Combination with Therasphere (yttrium-90) for Treatment of Hepatocellular Carcinoma (HCC) with Intent for Resection

Kulik, L. M.

Bristol-Myers Squibb Company

1/8/19 → 1/8/22

Project: Research project

REFINE: Regorafenib Observational Study in Hepatocellular Carcinoma

Kulik, L. M.

Quintiles, Inc., Bayer HealthCare Pharmaceuticals, Inc.

10/25/18 → 10/25/21

Project: Research project